Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Inflation Ablation Moves Market Higher. More details...
US Stem Cell Research Must Overcome Religion and...
CBT 200 Off By 20 Points. More details...
CBT 200 Drops 11 Points. More details...
Disease Is Less Common, But Deadly. More details...
Some Thoughts On The Pandemic To Come. More details...
CBT 200 Gives Up 13 Points. More details...
CBT 200 Gains 62 Points. More details...
CBT 200 Adds On 23 Points Today. More details...
CBT 200 Up Almost 4%. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
